Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Pharma
J&J leans on oncology growth drivers as Stelara sales slow
The company picked up a record $3 billion in quarterly sales for its multiple myeloma powerhouse Darzalex.
Zoey Becker
Oct 15, 2024 11:45am
Jazz's almost-withdrawn lung cancer drug shows life
Oct 15, 2024 10:15am
Sponsored
Privacy, Performance, and Emerging Media Channels: In Conversation with Jun Group
Oct 14, 2024 8:00am
Otsuka tots up 6-figure unpaid salary for dementia caregivers
Oct 15, 2024 7:15am
Sponsored
Samsung Biologics’ Manufacturing Capabilities for Complex Biomedicines
Oct 14, 2024 8:00am
Regulatory tracker: J&J's Tecvayli wins broader UK recommendation
Oct 14, 2024 4:33pm
